The renal proximal tubule plays a crucial role in drug metabolism and excretion and is an evaluation target in drug discovery. However, only a limited number of in vitro kidney models can be used as reliable alternatives to animal experiments. Traditional kidney cell lines lack physiological relevance due to low transporter expression, limited metabolic activity, and the absence of key renal-specific features, including tight junction formation and polarized transporter localization. In contrast, renal proximal tubular epithelial cells (RPTECs), derived from human renal proximal tubules, resemble native kidney epithelial cells by retaining key physiological properties such as active transport, selective permeability, and drug metabolism capabilities. As a result, RPTECs are widely used for nephrotoxicity studies. However, significant variability among commercially available RPTECs challenges their experimental reproducibility despite their potential as a promising alternative to animal-based renal studies. This study systematically compares multiple commercially available RPTECs, evaluating cell morphology, barrier function, and gene expression profiles to assess their suitability for in vitro kidney research. Our findings reveal substantial variability among RPTECs, emphasizing the need for careful cell selection. Notably, RPTEC/TERT1 exhibited stable barrier integrity, and showed maturation of transporter expression over time, making it a potentially reliable model for long-term studies. However, our results suggest that no single RPTEC model is universally optimal, and selection should be guided by specific applications, as transporter expression patterns and functional properties vary across RPTECs. Further standardizing and validating RPTEC-based models will be crucial for improving the reproducibility of renal studies and advancing drug discovery methodologies.
View full abstract